Company Overview and News

Zuckerberg On Safari To Washington

2018-04-07 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
Upvote Downvote

Chesapeake Energy: Elephant Temper Tantrum

2018-03-31 seekingalpha
Every now and then the elephant in the run stomps and makes a lot of noise. Investors had better pay attention because the problem that everyone hoped would never be voiced now makes the front pages followed by potentially more stock impact.
Upvote Downvote

Goodrich Petroleum's (GDP) CEO Gil Goodrich on Q4 2017 Results - Earnings Call Transcript

2018-03-01 seekingalpha
Good morning and welcome to the Goodrich Petroleum Year-End 2017 Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there'll be an opportunity to ask questions. [Operator Instructions] Please also note that today's event is being recorded.
Upvote Downvote

Goodrich Petroleum Corp. 2017 Q4 - Results - Earnings Call Slides

2018-03-01 seekingalpha
The following slide deck was published by Goodrich Petroleum Corp. in conjunction with their 2017 Q4 earnings call.
Upvote Downvote

Penny Stocks And Risk: This 97% Drop In 8 Months Teaches Investors Something

2018-02-21 seekingalpha
Many investors continue to believe that the investment risk correlates with the company's price per share.
Upvote Downvote

BRIEF-Goodrich Petroleum Announces Year-End Reserves

2018-02-14 reuters
Upvote Downvote

E&P Investors: 18+ Things To Watch In 2018 (Part 2)

2018-01-30 seekingalpha
In Part 1 of this article, I discussed my own views on certain macroeconomic factors that investors should follow in 2018, including global and U.S production and pricing levels.
Upvote Downvote

US Distillate Inventories Fell for the Third Time in 10 Weeks

US distillate inventories fell by 3.8 MMbbls (million barrels) or 2.7% to 139.2 MMbbls on January 5–12, 2018. The inventories also fell by 29.9 MMbbls or 18% from a year ago.
Upvote Downvote

India’s Crude Oil Imports Hit a Record in 2017

India is the world’s third-largest crude oil consumer. Its oil imports hit a record in 2017. India’s crude oil imports rose 1.8% to 4.3 MMbpd (million barrels per day) in 2017, according to Reuters. An increase in domestic demand led to the rise in refinery demand, which caused the rise in crude oil imports. India’s crude oil refining capacity increased to 5 MMbpd in 2H17. Any rise in crude oil imports from India is bullish for oil (UWT) (DWT) prices.
Upvote Downvote

Will Crude Oil Futures Rise or Fall This Week?

The EIA will release its weekly crude oil inventory report on January 18, 2018. OPEC will release its monthly oil market report on the same day. The IEA will release its oil market report on January 19, 2018.
Upvote Downvote

US Distillate Inventories Rose for the Seventh Time in 8 Weeks

US distillate inventories rose by 4.2 MMbbls (million barrels) to 143.1 MMbbls between December 29, 2017, and January 5, 2018, according to the EIA. Inventories rose 3.1% week-over-week but fell by 26.9 MMbbls or 16% YoY.
Upvote Downvote

The Suicide Mission Of Insider Buying At Chesapeake Energy

2018-01-07 seekingalpha
It is going to take a whole lot more than insider buying to make this stock a good investment decision.
Upvote Downvote

Russia’s Crude Oil Production Reached a 30-Year High

Russia’s crude oil production averaged 10.98 MMbpd (million barrels per day) in 2017, according to Russia’s Ministry of Energy. Production rose 0.1% year-over-year in 2017—a 30-year high. Production rose for the ninth consecutive year. Production rose 0.1% to 10.95 MMbpd in December 2017—compared to the previous month. Russia’s crude oil production increased despite ongoing output cuts.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...